Aguilar MI, Brott TG. Update in intracerebral hemorrhage. Neurohospitalist. 2011;1(3):148–59.

Article  PubMed  PubMed Central  Google Scholar 

Boyle PA, Yu L, Nag S, et al. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology. 2015;85(22):1930–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Case NF, Charlton A, Zwiers A, et al. Cerebral amyloid angiopathy is Associated with executive dysfunction and mild cognitive impairment. Stroke. 2016;47(8):2010–6.

Article  PubMed  Google Scholar 

Jäkel L, De Kort AM, Klijn CJM, Schreuder F, Verbeek MM. Prevalence of cerebral amyloid angiopathy: a systematic review and meta-analysis. Alzheimers Dement. 2022;18(1):10–28.

Article  PubMed  Google Scholar 

Wermer MJH, Greenberg SM. The growing clinical spectrum of cerebral amyloid angiopathy. Curr Opin Neurol. 2018;31(1):28–35.

Article  PubMed  Google Scholar 

Yamada M. Cerebral amyloid angiopathy: emerging concepts. J Stroke. 2015;17(1):17–30.

Article  PubMed  PubMed Central  Google Scholar 

Greenberg SM, Al-Shahi Salman R, Biessels GJ, et al. Outcome markers for clinical trials in cerebral amyloid angiopathy. Lancet Neurol. 2014;13(4):419–28.

Article  PubMed  PubMed Central  Google Scholar 

Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nat Rev Neurol. 2020;16(1):30–42.

Article  CAS  PubMed  Google Scholar 

Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H. Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry. 2019;90(8):870–81.

Article  PubMed  Google Scholar 

Abdelhak A, Foschi M, Abu-Rumeileh S, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol. 2022;18(3):158–72.

Article  CAS  PubMed  Google Scholar 

Mattsson N, Cullen NC, Andreasson U, Zetterberg H, Blennow K. Association between Longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer Disease. JAMA Neurol. 2019;76(7):791–9.

Article  PubMed  PubMed Central  Google Scholar 

Preische O, Schultz SA, Apel A, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease. Nat Med. 2019;25(2):277–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abu-Rumeileh S, Abdelhak A, Foschi M, et al. The multifaceted role of neurofilament light chain protein in non-primary neurological diseases. Brain. 2023;146(2):421–37.

Article  PubMed  Google Scholar 

Banerjee G, Ambler G, Keshavan A, et al. Cerebrospinal fluid biomarkers in cerebral amyloid Angiopathy. J Alzheimers Dis. 2020;74(4):1189–201.

Cheng X, Su Y, Wang Q, et al. Neurofilament light chain predicts risk of recurrence in cerebral amyloid angiopathy-related intracerebral hemorrhage. Aging. 2020;12(23):23727–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oeckl P, Halbgebauer S, Anderl-Straub S, et al. Glial fibrillary acidic protein in serum is increased in Alzheimer’s Disease and correlates with cognitive impairment. J Alzheimer’s Disease: JAD. 2019;67(2):481–8.

Article  CAS  PubMed  Google Scholar 

Elahi FM, Casaletto KB, La Joie R, et al. Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer’s disease. Alzheimers Dement. 2020;16(4):681–95.

Chatterjee P, Pedrini S, Stoops E, et al. Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease. Transl Psychiatry. 2021;11(1):27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Asken BM, Elahi FM, La Joie R, et al. Plasma glial fibrillary acidic protein levels differ along the Spectra of amyloid Burden and Clinical Disease Stage. J Alzheimer’s Disease: JAD. 2020;78(1):265–76.

Article  CAS  PubMed  Google Scholar 

Nichols NR, Day JR, Laping NJ, Johnson SA, Finch CE. GFAP mRNA increases with age in rat and human brain. Neurobiol Aging. 1993;14(5):421–9.

Article  CAS  PubMed  Google Scholar 

Greenberg SM, Charidimou A. Diagnosis of cerebral amyloid angiopathy: evolution of the Boston Criteria. Stroke. 2018;49(2):491–7.

Article  PubMed  PubMed Central  Google Scholar 

Voigt S, Amlal S, Koemans EA et al. Spatial and temporal intracerebral hemorrhage patterns in dutch-type hereditary cerebral amyloid angiopathy. Int J Stroke 2021:17474930211057022.

Google Scholar 

Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.

Article  PubMed  Google Scholar 

Tybirk L, Hviid CVB, Knudsen CS, Parkner T. Serum GFAP - reference interval and preanalytical properties in Danish adults. Clin Chem Lab Med. 2022;60(11):1830–8.

Article  CAS  PubMed  Google Scholar 

Gray E, Oeckl P, Amador MDM, et al. A multi-center study of neurofilament assay reliability and inter-laboratory variability. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21(5–6):452–8.

Article  PubMed  Google Scholar 

Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–38.

Article  PubMed  PubMed Central  Google Scholar 

Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351–6.

Article  CAS  PubMed  Google Scholar 

Potter GM, Chappell FM, Morris Z, Wardlaw JM. Cerebral perivascular spaces visible on magnetic resonance imaging: development of a qualitative rating scale and its observer reliability. Cerebrovasc Dis. 2015;39(3–4):224–31.

Article  PubMed  PubMed Central  Google Scholar 

Charidimou A, Martinez-Ramirez S, Reijmer YD, et al. Total Magnetic Resonance Imaging Burden of Small Vessel Disease in cerebral amyloid angiopathy: an imaging-pathologic study of Concept Validation. JAMA Neurol. 2016;73(8):994–1001.

Article  PubMed  PubMed Central  Google Scholar 

Dhiman K, Blennow K, Zetterberg H, Martins RN, Gupta VB. Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer’s disease pathogenesis. Cell Mol Life Sci. 2019;76(10):1833–63.

Article  CAS  PubMed  Google Scholar 

Qu Y, Tan CC, Shen XN, et al. Association of plasma neurofilament light with small Vessel Disease Burden in Nondemented Elderly: a longitudinal study. Stroke. 2021;52(3):896–904.

Article  CAS  PubMed  Google Scholar 

Duering M, Konieczny MJ, Tiedt S, et al. Serum neurofilament light chain levels are related to small Vessel Disease Burden. J Stroke. 2018;20(2):228–38.

Article  PubMed  PubMed Central  Google Scholar 

Gravesteijn G, Rutten JW, Verberk IMW, et al. Serum neurofilament light correlates with CADASIL disease severity and survival. Ann Clin Transl Neurol. 2019;6(1):46–56.

Article  CAS  PubMed  Google Scholar 

Reijmer YD, Fotiadis P, Martinez-Ramirez S, et al. Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy. Brain. 2014;138(1):179–88.

Article  PubMed  PubMed Central  Google Scholar 

Fotiadis P, Reijmer YD, Van Veluw SJ, et al. White matter atrophy in cerebral amyloid angiopathy. Neurology. 2020;95(5):e554–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wilcock DM, Vitek MP, Colton CA. Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer’s disease. Neuroscience. 2009;159(3):1055–69.

Article  CAS  PubMed  Google Scholar 

Foerch C, Curdt I, Yan B, et al. Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J Neurol Neurosurg Psychiatry. 2006;77(2):181–4.

Article  CAS  PubMed  Google Scholar 

Garwood CJ, Ratcliffe LE, Simpson JE, Heath PR, Ince PG, Wharton SB. Review: astrocytes in Alzheimer’s disease and other age-associated dementias: a supporting player with a central role. Neuropathol Appl Neurobiol. 2017;43(4):281–98.

Article  CAS  PubMed  Google Scholar 

Shir D, Graff-Radford J, Hofrenning EI, et al. Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer’s disease and vascular pathology. Alzheimers Dement (Amst). 2022;14(1):e12291.

Article